Adenovirus-mediated Intraarterial delivery of PTEN inhibits neointimal hyperplasia

被引:42
作者
Huang, J
Niu, XL
Pippen, AM
Annex, BH
Kontos, CD
机构
[1] Duke Univ, Med Ctr, Div Cardiol, Dept Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
关键词
apoptosis; PTEN; vascular biology; neointimal hyperplasia; phosphoinositide; 3-kinase;
D O I
10.1161/01.ATV.0000151619.54108.a5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Phosphoinositide ( PI) 3- kinase promotes vascular smooth muscle cell ( VSMC) responses necessary for neointimal hyperplasia. We recently demonstrated that the inositol 3- phosphatase PTEN is expressed in VSMCs and that its overexpression inhibits these cellular responses. The purpose of this study was to determine the effects of adenovirus- mediated overexpression of PTEN on neointimal hyperplasia in vivo in the rat carotid injury model. Methods and Results - Rat carotid arteries were balloon- injured and treated with a recombinant control adenovirus ( AdEV) ( n = 6), an adenovirus encoding wild- type PTEN ( AdPTEN) ( n = 8), or phosphate- buffered saline ( sham) ( n = 5). Injured vessels demonstrated PTEN overexpression by Western blotting and immunohistochemistry after AdPTEN treatment. Neointimal hyperplasia was assessed 2 weeks after balloon injury and adenovirus administration. Compared with controls, AdPTEN treatment significantly decreased neointimal area and percent stenosis. To investigate the mechanisms of action of AdPTEN, vessels were harvested 3 days after balloon injury and virus infection. AdPTEN significantly increased medial cell apoptosis while decreasing proliferation of the remaining viable cells. Conclusions - PTEN overexpression potently inhibits neointimal hyperplasia through induction of apoptosis and inhibition of medial cell proliferation. These findings suggest that modulation of PTEN expression or activity may be a viable approach to treat neointimal hyperplasia.
引用
收藏
页码:354 / 358
页数:5
相关论文
共 32 条
[1]   Cell cycle progression - New therapeutic target for vascular proliferative disease [J].
Braun-Dullaeus, RC ;
Mann, MJ ;
Dzau, VJ .
CIRCULATION, 1998, 98 (01) :82-89
[2]   New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway [J].
Cantley, LC ;
Neel, BG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4240-4245
[3]  
Chavakis E, 2001, CIRCULATION, V103, P2102
[4]  
CLOWES AW, 1983, LAB INVEST, V49, P208
[5]   Phosphoinositide kinases [J].
Fruman, DA ;
Meyers, RE ;
Cantley, LC .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :481-507
[6]  
GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431
[7]   Regulation of translation initiation by FRAP/mTOR [J].
Gingras, AC ;
Raught, B ;
Sonenberg, N .
GENES & DEVELOPMENT, 2001, 15 (07) :807-826
[8]   A simplified system for generating recombinant adenoviruses [J].
He, TC ;
Zhou, SB ;
da Costa, LT ;
Yu, J ;
Kinzler, KW ;
Vogelstein, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2509-2514
[9]   Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN [J].
Huang, JH ;
Kontos, CD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) :745-751
[10]   PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects [J].
Huang, JH ;
Kontos, CD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :10760-10766